Hire Lorant Kovacs, a pharma consultant specializing in Clinical Studies and FDA Inspections. See services offered, experience summary, and connect via apicule.
Based in: Hungary
Willing to work in: Europe, North America, South America
Consultant Type: Independent Consultant
Expertise summary: Lorant Kovacs is an independent pharmaceutical consultant with over 25 years of experience in API manufacturing and quality assurance. His expertise supports Chemistry, Manufacturing and Controls (CMC) and FDA Inspection Readiness, with a background in API technology transfer, scale-up, validation oversight, and manufacturing quality systems. He has held leadership and consulting roles with Gedeon Richter, Ofichem Group, Soneas Chemicals, and Validant Consulting for Teva. His experience includes managing more than 50 technology modernization, scale-up, and transfer projects, alongside preparing API facilities for FDA and European regulatory inspections. He helps pharmaceutical manufacturers strengthen manufacturing controls, review qualification and validation documentation, and prepare teams and quality systems for inspections. - Show More


Lorant supports the manufacturing and quality aspects of CMC for APIs, drawing on experience in technology transfer, scale-up, and process modernization. His work includes reviewing and approving qualification documents, validation master plans, and analytical, process, and cleaning validation protocols and reports. He helps teams strengthen manufacturing controls and supporting technical documentation throughout production changes and technology transfers.

Lorant supports FDA inspection preparation for API manufacturing facilities through departmental checklists, documentation review, and quality system oversight. His experience includes preparing steroid API operations for inspections and guiding manufacturing and QA teams through regulatory assessments. He also brings consulting experience in batch record review, deviation investigations, requalification activities, and assisting site personnel with responses to FDA questions.